SLS

SELLAS Life Sciences Healthcare
13.32 live · 2026-08-31 15:59
55.2%
Brown Bear Score
20.3%
Business Conviction Score
74.3%
Position Health Score
30.9%
Chase Risk
My watchlist
Daily closes
1.394.918.4311.9415.4613.34

Daily closes · 1Y (252 sessions) · +594.8% · range 1.39–15.46

Score trends appear once the scores have been recorded on more than one trading day.

The Businesswhat the company reports

Business & cash flow

FCF / revenue
Gross margin 0.0%
ROIC 0.0%
Forward P/E -133.4

No annual filing with both total assets and a cash-flow figure is cached for this name, so neither validated measure can be computed. FCF/revenue is shown instead, which is not the validated measure.

What the company does

We are a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications.

From the company's most recent annual report filed with the SEC, shown as filed — this is the company describing its own business, not a Brown Bear assessment. Read the filing.

Price vs Earnings growth

Trailing EPS is negative (-0.22) and forward EPS is not positive, so a growth percentage does not exist

Confidence 25.0/100

Drivers

Trailing price return (1y) +594.8%

Figures

Trailing EPS -0.22
Forward EPS -0.10
Forward P/E -133.40

Takeaway Low data confidence (limited analyst coverage) — treat this section as informational only.

Valuation: dearer or cheaper than usual

Brown Bear holds too few quarterly filings for this company to measure a valuation range.

Dividends: what it pays you

SLS pays no dividend. Any return from owning it has to come from the share price. That is an ordinary choice rather than a fault — a company keeping its profit is reinvesting it, buying back shares, or holding it.

Debt levels

Total debt$0
Cash & equivalents$138.3M
Net debt −$138.3M
Debt / equity0.00x

From the balance sheet in the company's most recent SEC filing (as of 2018-12-31) — not scored or gauged. "Healthy" debt varies hugely by industry: a utility or a REIT normally carries far more leverage than a software company as a matter of course, so this is context to weigh against the rest of the page, not a pass/fail reading. Net debt is negative here — the company holds more cash than debt.

The Pricewhat the chart is doingTop ↑

Price Levels

StrategyFair Value Anchor
Reference band 10.60 — 13.41
Protective stop 8.89 (Atr, 26.0% risk)
Support 4.84 (2 touches, 175.9% away)
Resistance 13.65 (2.4% away)

Takeaway The shares are nearer the ceiling than the floor: about 2.4% below 13.65, where sellers have turned up before, and 175.9% above 4.84, where buyers have stepped in before. That floor has held 2 times, which is how it was spotted. If someone bought at today's price and sold if it dropped through the level below, they would be about 26.0% out of pocket. That is all this figure means — an illustration of the risk, not a price to sell at.

Levels are computed from price structure. They describe where the engine locates support and extension — they are not targets, and not advice.

Ichimoku Cloud (Adaptive)

Daily cloudPrice INSIDE the cloud | periods 6/18/37 (71% of classic 9/26/52)
LinesTenkan/Kijun BULL | cloud twist BULL (fresh up, 6d ago)
Cloud thickness51% percentile
Chikou spanAbove price from 26 periods ago
Weekly cloudPrice ABOVE the weekly cloud (context only, not scored)

Takeaway The stock is trading inside its cloud — a shaded band drawn from several of its own moving averages, currently 12.43 to 13.46. Inside the band those averages disagree with each other, so the indicator is not saying much either way. Its shorter-term averages point the other way, so this is a mixed reading rather than a clear one.

Trailing returns

21 days +33.3%
63 days +47.1%
126 days +164.2%
252 days +594.8%
Below 252d high13.7%

Trend context

PositionFar above trend
ExtensionExtended
Trend slopeRising strongly
Direction of travelConverging back to trend

Takeaway Positive Kalman trend with moderate extension; constructive for momentum but watch entry risk.

Volatility

State No recent compression
Current band width39.1% of price
Recent tightest33.2% (9 sessions ago, narrower than 70.0% of its history)
Expansion since1.18×
Band 10.42 — 15.49

Takeaway Lately this share price has been swinging around inside a range roughly 39% wide. That is normal for this stock, so there is nothing unusual to read into it either way.

Who's Tradingthe flow behind the priceTop ↑

Insider activity

ActivityNo filings in the window
Buy filings0
Sell filings0

Open-market Form 4 purchases and sales over the last 75 days, read from SEC EDGAR Form 4. Grants, option exercises, gifts and shares withheld for tax are excluded — they are compensation mechanics, not a decision to buy or sell. Reported Form 4 activity. Brown Bear tested insider cluster-buying as a return signal and rejected it as era-unstable; shown as fact, not signal.

Volume confirmation

Volume-price trend Above its signal line
Confirmation Marginal

No absorption or distribution event in the recent window.

Takeaway Slightly more shares change hands on rising days than on falling ones, but the gap is too small to read anything into.

Options Positioning

No binary-event flag

SLS: no binary-event flag. Near IV 142%, far IV 176% (ratio 0.81), implied move 19.7%.

Implied volatility 142% near (11d) · 176% far (137d)
Term structure 0.81× near/far
Historical volatility 103%
Implied vs historical 1.38×
Implied move ±19.7% by 2026-09-11
Implied move vs ATR 0.63×
Skew Flat (0.95×)
Call wall 30.00 (+124.9% away)
Put wall 10.00 (-25.0% away)
Gamma pin 5.00

Takeaway Insuring against a move in this stock costs less for the next few weeks than for the next few months, which is the normal state of affairs and suggests no particular date is worrying anyone. Options traders are positioned for a move of around 19.7% in either direction by 2026-09-11.

Chain as at 2026-08-31. This is a risk read on whether a specific event is being priced — not a directional view.

Context & Methodthe record, and how it was builtTop ↑

Relative Rotation

ImprovingLeadingLaggingWeakeningvs sectorvs SPYsector vs SPYRS-Ratio →RS-Momentum →

Leadership Cooling

Rotation health 90.3/100; Strong Rotation Tailwind.

Rotation health 90.3
Rotation strength 66.9
LegQuadrantRS-RatioRS-Mom
Stock vs sector Leading 112.1 103.8
Stock vs SPY Leading 111.7 103.3
Sector vs SPY Leading 103.2 104.6

Direction of travel: South-East / trend strong but momentum cooling

Position only. Brown Bear's RRG redesign programme is closed — five constructions, none beat an appropriate null — so this section describes where the name sits, and is not a signal.

News Headlines

  1. Loading headlines\u2026

Headlines are supplied by third-party feeds and are not written, ranked or interpreted by Brown Bear. They feed no score on this page.

Detailed Scoring

Positive signals

  • Piotroski F-score 5/9 (+5.0)
  • Altman Z-score 3.00 (+3.0)
  • High earnings quality (accrual ratio 0.000) (+1.0)
  • Relative Strength 7.8% vs sector: OUTPERFORMING (+10.0)
  • Track 2: MACD line/signal trend quality (+10.0)
  • Track 2: positive MACD trend regime (+10.0)
  • Track 2: volume expansion 1.05x average (+0.3)
  • Track 2: relative strength trend improving (+10.0)
  • Track 2: 20-day momentum acceleration 0.38 (+20.0)
  • Track 2: bullish DI spread 23.7 (+12.0)
  • Track 2: ADX 56.5 and rising (+18.0)
  • Track 2: relative momentum rank 1.00 (+15.0)
  • Track 2: price above EMA20 by 1.3% (+1.1)
  • Track 2: EMA20 slope expanding 3.6% (+8.0)
  • Track 2: VPT strength 0.03 (+0.6)
  • Track 2: price above EMA50 by 11.8% (+9.5)
  • Track 2: EMA50 slope improving 9.2% (+6.0)
  • Track 2: Bollinger position 0.58 (+4.6)

Negative signals

  • Track 2: MACD histogram deteriorating (-0.29)
  • Track 2: RSI deterioration/overheating 60.8, 5-day change -5.1
  • FCF margin unavailable: revenue missing from fundamentals cache
  • Track 2 structural exemption: structural score 9.0/100 below the 25 quality floor; this is an unowned speculative candidate, so the universal SELL gate was skipped and the Track 2 momentum/RRG grid was allowed to evaluate instead. Structural quality here is weak by design for this kind of candidate -- treat any resulting BUY as higher risk than a Track 1 signal.

Chase risk is not elevated for this name, so extension penalties are omitted from the negative signals above.